Insilico Medicine Cayman Topco Sustainability Reports
The company operates an artificial intelligence-driven biotechnology platform specializing in drug discovery and pipeline development. It offers target identification, small molecule generation, and clinical outcome prediction services through its Pharma.AI software platform.
Sector: Professional & technical services
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
LEI: 254900MQK3C1TR58H275
FIGI: BBG01Z36GZM5
1 reports from 2025 to 2025
